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Abstract Mitochondria play a critical role in cell death by releasing apoptogenic factors, such as cytochrome c and
apoptosis-inducing factor (AIF), from the intermembrane space into the cytoplasm. Because mitochondrial dysfunction
has been shown to be involved in several neurodegenerative diseases, mitochondrial toxins are largely used to model
these disorders. These include 3-nitropropionic acid (3-NP), an irreversible inhibitor of succinate dehydrogenase, which
has been used to model Huntington’s disease and was previously reported by us to induce apoptotic cell death through
caspase activation. In the present study, we evaluated the involvement of caspase-independent neuronal cell death
induced by 3-NP (1 mM) and the effect of z-VDVAD-fmk, an inhibitor of caspase-2, using cortical neurons in culture. Our
results highly suggest that 3-NP induces both caspase-dependent and -independent cell death. We showed that z-
VDVAD-fmk prevented both caspase-2 and -3-like activities evoked by 3-NP, but only partly prevented chromatin
fragmentation/condensation. However, z-VDVAD-fmk did not avoid 3-NP-induced release of cytochrome c or AIF from
mitochondria nor did it affect the levels of mitochondrial Bax. Furthermore, 3-NP-mediated decrease in plasma
membrane integrity was not affected by z-VDVAD-fmk. Under these conditions, the inhibitor prevented the caspase-
dependent cell death. J. Cell. Biochem. 98: 93–101, 2006.  2005 Wiley-Liss, Inc.
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Caspases are cysteine proteases that mediate
apoptotic cell death in a variety of cells,
including neurons. Caspases can be activated
through extrinsic or intrinsic pathways. The
latter is used by most neurons in several
pathological conditions. This pathway impli-
cates the release of cytochrome c from
mitochondria, which recruits Apaf-1 and pro-
caspase-9, forming the apoptosome. As a
consequence, caspase-9 is activated and subse-
quently other caspases are also activated.
Although caspase-9 is generally believed to be
the initiator caspase in stress-induced apopto-
sis, more recent studies suggest that caspase-2
can act upstream ofmitochondria [Lassus et al.,
2002; Robertson et al., 2002]. According to this,
caspase-2 can induce cytochrome c, Smac and
apoptosis-inducing factor (AIF) release from
mitochondria [Guo et al., 2002; Paroni et al.,
2002; Robertson et al., 2002]. It was also
described that procaspase-2 can be recruited to
a highmolecular weight complex (similar to the
apoptosome in which procaspase-9 is activated)
independently from cytochrome c and Apaf-1.
The recruitment of caspase-2 to this complex is
sufficient to mediate its activation [Read et al.,
2002]. The individual components of this com-
plex have yet to be identified.
In addition to the pathwaydescribedabove, in
which cell death is mediated by caspase activa-
tion, there are other pathways leading to
cell death that do not rely on the activity of
caspases. In this form of cell death, two
endonucleases, AIF and endonuclease G, are
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proposed to translocate from the mitochondrial
intermembrane space to the nucleus, where
they are involved in DNA fragmentation and
chromatin condensation [Susin et al., 1999; Li
et al., 2001]. Whether these proteins are co-
released during apoptosis or require activation
of initiator caspases remains controversial.
There is substantial evidence that apoptosis
and caspase activation contribute to neurode-
generation associated with Huntington’s dis-
ease (HD) [Portera-Cailliau et al., 1995; Kiechle
et al., 2002]. Caspase-1, -3, -8 and -9 activation
has been demonstrated in end-stage HD trans-
genic mice or in post-mortem human HD brain
[Ona et al., 1999; Sanchez et al., 1999; Chen
et al., 2000; Kiechle et al., 2002]. More recent
studies reported that caspase-2 and -6 also play
important roles in HD pathogenesis [Hermel
et al., 2004]. Using a mitochondrial model of
HD, the 3-nitropropionic acid (3-NP), we pre-
viously showed that Bcl-2 overexpression pre-
vented the activation of caspase-2, -3 and -6
induced by 3-NP (0.3 mM) [Brito et al., 2003].
We also demonstrated that cytochrome c-
dependent activation of caspase-3 could be
prevented by regulating Bcl-2 family proteins
in the mitochondria, in the presence FK506, a
classical inhibitor of calcineurin [Almeida et al.,
2004]. Because we observed that caspase-2 was
also activated by 3-NP concentrations 1 mM,
in the present study we examine the effect of z-
VDVAD-fmk, a caspase-2 inhibitor, on 3-NP-
induced cell death using rat primary cortical
neurons. Our results show that cell death
evoked by 3-NP is only partly mediated by
caspase activation. The observation that AIF is
released frommitochondria suggests a caspase-
independent cell death pathway. The inhibition
of caspase-2 and -3 by z-VDVAD-fmk counter-
acted the activation of the caspase-dependent
pathway, partly preventing cell death involving
chromatin fragmentation/condensation.
MATERIALS AND METHODS
Materials
Neurobasal medium and B-27 supplement
were purchased from GIBCO (Paisley, UK). 3-
Nitropropionic acid, 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT),
benzyloxycarbonyl-Val-Asp-Val-Ala-Asp-fluor-
omethyl ketone (z-VDVAD-fmk), N-acetyl-Val-
Asp-Val-Ala-Asp-p-nitroanilide (Ac-VDVAD-
pNA) and anti-a-tubulin were from Sigma
Chemical Co. (St. Louis, MO). N-acetyl-Asp-
Glu-Val-Asp-p-nitroanilide (Ac-DEVD-pNA)was
obtained from Calbiochem (Darmstadt, Ger-
many). Primary antibodies anti-cytochrome c,
anti-Bax and anti-AIF were from PharMingen
(San Diego, CA), Cell Signaling (Beverly, MA)
and Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA), respectively. Hoechst 33342 and
Mitotracker-red CMXRos were from Molecular
Probes (Eugene, OR). All other reagents were of
analytical grade.
Cell Culture
Primary neuronal cultures of rat cerebral
cortical neurons were prepared as previously
described [Almeida et al., 2004]. In brief,
cerebral cortices were dissected from fetal rats
of the Wistar strain at 16–17 days and the cells
dissociated. After that, cells were resuspended
in Neurobasal medium supplemented with 2%
B-27, 0.2 mM glutamine, 100 U/ml penicillin
and 0.1 mg/ml streptomycin and cultured in a
humidified incubator at 378C (95% air and 5%
CO2). After 5–6 days in culture, neurons were
incubated with 1 mM 3-NP for 24 h. When
applied, the cells were pretreated for 20–30min
with 1 or 3 mM z-VDVAD-fmk, a cell permeable
inhibitor that contains the aminoacid sequence
recognised by caspase-2 [Talanian et al., 1997],
before incubation with 3-NP. The stock solution
of 3-NP was prepared in water and brought
to pH 7.4 with NaOH. Stock solutions of z-
VDVAD-fmk were prepared in DMSO.
MTT Assay
The reduction status of cells wasmeasured by
a colorimetric assay for cell survival, using 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT), according to the method
described byMosmann [1983]. MTT (0.5mg/ml)
in Naþ medium (in mM: 132 NaCl, 1.2
NaH2PO4, 1.4 MgCl2, 4 KCl, 10 HEPES, 6
glucose and 1 CaCl2, pH 7.4) was added to the
cultures and incubated for 2 h at 378C in the
dark. When taken up by living cells, MTT is
converted to a water-insoluble blue product
(formazan). The precipitated dye was dissolved
in 0.04 M HCl in isopropanol and colorimetri-
cally quantitated (absorbance at 570 nm).
Values were expressed as the percentage of
optical density of control cells, in the absence of
3-NP or z-VDVAD-fmk. To exclude the possible
effect ofDMSO (used as a vehicle) per se, control
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cells were treated with DMSO (0.1% in the
medium).
Lactate Dehydrogenase (LDH) Measurements
Assessment of intracellular LDH was deter-
mined after lysing the cells with 10mMHEPES
(pH 7.4) plus 0.01% Triton X-100, and freezing
at 808C. Cell debris in both aliquots (intra
and extracellular) were removed by centrifuga-
tion at 14,000 rpm (Eppendorf Centrifuge
5417R), for 10 min. LDH activity was deter-
mined spectrophotometrically (Perkin-Elmer
Lambda-2), by following the rate of conversion
of reduced nicotinamide adenine dinucleotide
(NADH) to oxidised nicotinamide adenine dinu-
cleotide (NADþ) at 340 nm, according to the
method of Bergmeyer and Bernt [1974]. LDH
released into the extracellular medium was
expressed as a percentage of total LDH activity
in the cells.
Caspase Protease Activity Assay
Caspase-like activities were determined as
described previously [Almeida et al., 2004].
Briefly, cortical cells were lysed and centrifuged
at 14,000 rpm (Eppendorf Centrifuge 5417R) for
10 min. The resulting supernatants were
assayed for protein content by the Sedmak
method [Sedmak and Grossero, 1977]. Cas-
pase-2 and -3-like activities were tested on
peptidic substrates using, respectively, Ac-
VDVAD-pNA andAc-DEVD-pNA. Caspase-like
activities were calculated as the increase above
the control, for equal protein loading (25 mg).
Nuclear Morphology Assay
The nuclear morphology of cortical neurons
was analysed by fluorescence microscopy using
Hoechst 33342 dye. After incubation for 24 h,
the medium was replaced by new Neurobasal
medium and the cortical neurons remained in
culture for an additional 24 h (without z-
VDVAD-fmk or 3-NP). Then, cells were washed
briefly in phosphate buffer (PBS, in mM: 137
NaCl, 2.7 KCl, 1.4 K2HPO4, 4.3 Na2HPO4,
pH 7.4), fixed in 4% paraformaldehyde (pH
7.4) for 10 min and incubated with 7.5 mg/ml
Hoechst for 10min. Afterwashing twice in PBS,
the coverslips were immobilized on a glass slide
with mounting medium. Fluorescence of
stained chromatin was examined and the
fragmented and condensed chromatin was
scored using a Nikon Diaphot TMD microscope
(Nikon Corporation, Tokyo, Japan), with a
triple XF-63 Omega filter (Omega Optical,
Inc., Brattleboro, VT).
Immunocytochemistry
After incubation for 24 h, cells were exposed
to 750 nM Mitotracker-red in Naþ medium for
1 h, at 378C in the dark. Then, cellswerewashed
in PBS, fixed in 4% paraformaldehyde (pH 7.4)
for 10 min and incubated in PBS containing
20 mM glycine for 10 min. The cells were
permeabilised with 0.1% saponin in PBS for
30 min and incubated with anti-cytochrome c
(1:100, against its native form) for another
30 min. Next, cells were washed and incubated
with Alexa Fluor 488 (1:200) for 30 min. After
washing twice in PBS, the coverslips were
immobilized on a glass slide with mounting
medium and fluorescence was examined by
confocal microscopy (Bio-Rad MRC 600).
Western Blotting Analysis
Mitochondrial fractions were prepared from
cortical neurons as described previously
[Almeida et al., 2004]. Protein content was
determined using the Bio-Rad reagent accord-
ing to the manufacturer’s instructions. Equiva-
lent amounts of protein were separated on a
15% SDS–PAGE gel and electroblotted onto
polyvinylidene difluoride (PVDF) membranes
(Amersham). After blocking with 5% skim milk
inTBS (25mMTris/HCl, pH7.6, 150mMNaCl)/
0.1% Tween, for 2 h (RT), the membranes were
incubated with the antibodies directed against
the denatured form of cytochrome c (1:500),
Bax (1:1,000), or AIF (1:1,000) overnight, at
48C. The membranes were further incubated
with the secondary antibody (1:20,000) for 2 h
(RT) and the proteins were visualized by using
an enhanced chemifluorescence reagent (Amer-
sham Biosciences, Buckinghamshire, UK). The
antibody directed against a-tubulin (1:20,000)
was used to normalize the amount of protein
per lane.
Statistical Analysis
Data were expressed as meanSEM of the
number of experiments indicated in the figure
legends. Comparisons among multiple groups
were performed with a one-way analysis of
variance (ANOVA) followed by a Tukey–Kra-
mer post-hoc test. Comparisons between two
groups were achieved with Student’s t-test
(GraphPad Prism version 3.0). Significance
was accepted at P< 0.05.
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RESULTS
We have previously reported that exposure of
rat cortical neurons to 3-NP induces activation
of several caspases, namely caspase-2, -3, -8 and
-9, in a dose dependent manner [Almeida et al.,
2004]. In the present study, we determined the
effect of z-VDVAD-fmk, a cell-permeable inhi-
bitor that contains the aminoacid sequence
recognised by caspase-2 [Talanian et al.,
1997], in primary cortical neurons exposed to
1 mM 3-NP, a concentration shown to signifi-
cantly increase the activity of caspase-2
[Almeida et al., 2004]. As shown in Figure 1
(A, B), 1mM3-NP induced a 2.5-fold increase in
both caspase-2 and -3-like activities. A concen-
tration of 3 mM z-VDVAD-fmk was required
to completely prevent caspase-2-like activity
(P< 0.01). Under these conditions caspase-3-
like activity was also completely prevented
(P< 0.01) (Fig. 1B).
Because z-VDVAD-fmk completely prevented
both caspase-2 and -3 activities, we next exam-
ined the effect of the inhibitor in the mitochon-
drial apoptotic pathway, by analysing the levels
ofpro-apoptoticproteins.UsingMitotracker-red,
a mitochondrial marker also sensitive to mito-
chondrial membrane potential [Bae et al.,
2005], we observed that z-VDVAD-fmk did not
prevent the decrease in mitochondrial mem-
brane potential induced by 3-NP (Fig. 2A).
z-VDVAD-fmk was also unable to prevent the
loss of mitochondrial cytochrome c (Fig. 2A,B)
induced by 3-NP, as observed by immunocyto-
chemistry and Western blotting. Labelling of
cytochrome c in cytosolic fractions was not
changes by z-VDVAD-fmk either (data not
shown). In fact, the inhibitor decreased mito-
chondrial cytochrome c per se by about 20%
(Fig. 2B), but did not affect the labelling of
Mitotracker-red (Fig. 2A). We also observed
that z-VDVAD-fmkdidnot prevent the decrease
of mitochondrial AIF induced by 3-NP (Fig. 2C).
Furthermore, both mitochondrial (Fig. 2D) and
cytosolic (data not shown) Bax levels remained
unchanged upon exposure to 3-NP and/or
z-VDVAD-fmk.
As a means to evaluate the role of the
inhibitor in preventing cell death due to inhibi-
tion of caspase-3, we next analysed cells enter-
ing into apoptosis by examining the nuclear
morphology of cortical neurons exposed to 1mM
3-NP for 24 h, plus 24 h in the absence of any
stimuli, using Hoechst 33342 (Fig. 3). This dye
allows the measurement of chromatin altera-
tions due to caspase-3 activation and AIF
release. Other methods like DNA laddering
only measure caspases contribution, since cas-
pase-independent cell death does not lead to a
DNA laddering pattern [Maianski et al., 2003;
Fig. 1. 3-NP-mediated caspase-2 and -3 activation-effect of z-
VDVAD-fmk. Cortical cultures were pretreated with 1 or 3 mM z-
VDVAD-fmk and then incubated in the absence or in the
presence of 1 mM 3-NP, for 24 h. Caspase-2 (A) or caspase-3 (B)
-like activities were measured by following the cleavage of the
colorimetric substrates Ac-VDVAD-pNA or Ac-DEVD-pNA,
respectively. The activity was expressed as the increase of
optical density above the control (cells maintained in the absence
of 3-NP and z-VDVAD-fmk). The results were expressed as the
mean SEM of three to six distinct experiments. Statistical
analysis: ***P<0.001, compared to the control; ##P< 0.01,
compared to 3-NP-treated neurons, in the absence of z-VDVAD-
fmk.
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Chipuk and Green, 2005]. Control cells showed
about 24.8 1.1% apoptotic cells, with con-
densed and/or fragmented chromatin. In the
presence of 1 mM 3-NP, the number of viable
cells decreased about 22.4 2.5% (P< 0.01),
relatively to the control (untreated neurons).
Under these conditions, z-VDVAD-fmk only
partly prevented 3-NP-induced apoptotic mor-
phology (by 8.1 1.1%, P< 0.05) (Fig. 3A,B). In
addition, we analysed the effect of the inhibitor
on the reducing capacity of cortical neurons and
on the integrity of plasma membrane, by
following the MTT reduction assay and the
leakage of LDH, respectively. 3-NP (1 mM)
decreased the capacity of cells to reduceMTT by
29.1 0.8% (P< 0.001) (Fig. 4A), and increased
the LDH released into the medium by
8.3 2.4% (P< 0.05) over the control (Fig. 4B).
However, the caspase inhibitor did not prevent
these alterations.
These results suggested that chromatin frag-
mentation/condensation induced by 1mM3-NP
results from both cytochrome c-mediated
caspase-3 activation and AIF released from
mitochondria, in a process that does not de-
pend on Bax translocation to this organelle.
Under the concentration affecting caspase-2
activity, z-VDVAD-fmk (3 mM) did not prevent
Fig. 2. Effect of 3-NP and z-VDVAD-fmk on mitochondrial
proteins. Cortical neurons were pretreated with 3 mM z-VDVAD-
fmk and then incubated in the absence or in the presence of 1 mM
3-NP, for 24 h. A: Cells were labelled with Mitotracker-red (red)
and cytochrome c (green). Fluorescence co-localisation (yellow)
indicates retention of cytochrome c in the mitochondria.B, C, D:
Mitochondrial fractions prepared from cortical neurons were
analyzed by SDS–PAGE followed by Western blotting for
cytochrome c (B), AIF (C) and Bax (D). Blots are representative
from three to four different experiments producing the same
results. Graphs show densitometric analysis performed by
normalizing the bands of mitochondrial proteins to a-tubulin.
Data were expressed as the mean SEM of all experiments.
Statistical analysis: *P< 0.05, **P<0.01, ***P<0.001, compar-
ed to untreatedneurons. [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
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mitochondria permeabilization, nor did it affect
the loss of cell viability, suggesting that part of
the protective effect observed in Figure 3, may
result from the inhibition of caspase-3.
DISCUSSION
In the present study, we show that 3-NP
(1 mM) induces the release of mitochondrial
cytochrome c and AIF. z-VDVAD-fmk prevents
both caspase-2 and -3-like activities induced by
3-NP and slightly prevents chromatin fragmen-
tation/condensation. However, z-VDVAD-fmk
does not prevent 3-NP-induced release of cyto-
chrome c or AIF from mitochondria, nor does it
affect necrotic/late apoptotic features of cell
death, determined by loss of plasma membrane
integrity.
During the past years large amount of
information has been gathered to elucidate the
mechanism leading to cell death upon 3-NP
treatment. Using the same concentration of 3-
NP as in the present study, Pang and Geddes
[1997] showed 50% hippocampal cell loss after
48 h of treatment, which corresponded to both
necrotic and apoptotic features. Although the
rapid necrotic cell death was blocked by the
NMDA receptor antagonist MK801, apoptosis
was not attenuated by this compound but
instead prevented by a protein synthesis inhi-
bitor, cycloheximide. These data indicated that
3-NP-induced apoptosis required de novo gene
expression. Alterations in gene expression are
triggered by specific intracellular pathways
that control the phosphorylation state of
nuclear transcription factors. In accordance,
Garcia et al. [2002] showed nuclear transloca-
tion of activated JNK, as well as hyperpho-
sphorylation of the transcription factor c-Jun in
striatal neurons upon 3-NP treatment. One
possible target gene of the JNK/c-Junmodule is
the Fas ligand (FasL), as previously proposed
based on different model systems of neuronal
apoptosis [Le-Niculescu et al., 1999; Martin-
Villalba et al., 1999; Morishima et al., 2001].
The binding of FasL to its cognate receptor can
lead to the activation of caspase-8. We pre-
viously showed that 3-NP (1mM) induced a two-
fold activation of caspase-8 [Almeida et al.,
2004], raising the hypothesis of an involvement
of JNK/c-Jun and the activation of FasL
receptor.
Fig. 3. Effect of z-VDVAD-fmk on chromatin morphology upon
exposure to 3-NP. The cells were pretreated with 3 mM z-
VDVAD-fmk and further exposed to 1 mM 3-NP, for 24 h. After
incubation, the medium was replaced by new Neurobasal
medium and the cortical neurons remained in culture for more
24 h (without z-VDVAD-fmk or 3-NP). Fixed cells were labelled
with Hoechst 33342 and assayed for chromatin fragmentation/
condensation.A: Representative images of the cells: a, untreated
cells; b, 3 mM z-VDVAD-fmk; c, 1 mM 3-NP; d, z-VDVAD-fmk
plus 3-NP. The arrows show fragmented/condensed chromatin.
B: Quantification of viable cells (without fragmented/condensed
chromatin). Cell viability was expressed as a percentage of the
total number of cells (approximately 100 cells per field were
counted). Results were expressed as the mean SEM of four
distinct experiments, performed in duplicates or triplicates.
Statistical analysis: **P< 0.01, compared to untreated neurons;
#P<0.05, compared to 3-NP-treated neurons. [Color figure
can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
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Under the present experimental conditions
3-NP-induced caspase-2 activation may have
contributed for the release of cytochrome c.
Previously, Enoksson et al. [2004] showed
that despite permeabilising the outermitochon-
drial membrane and causing cytochrome c
release from this organelle, caspase-2 also
disrupted the interaction of cytochrome c with
anionic phospholipids, namely cardiolipin, and
enhanced the release of this hemoprotein
caused by an apoptotic stimulus. Nevertheless,
complete blockade of caspase-2 activity by z-
VDVAD-fmk (3 mM) did not prevent 3-NP-
induced cytochrome c release. Taking into
account that caspase-8 is activated by 3-NP
[Almeida et al., 2004], truncated Bid may
trigger the release of cytochrome c. On the other
hand, 3-NP-induced decrease of mitochondrial
membrane potential may directly account for
the release of this hemoprotein through the
opening of the permeability transition pore
[Green and Reed, 1998].
In addition, we showed that, in contrast to
cytochrome c, z-VDVAD-fmk did not affect the
release of AIF per se. In recent studies, Uren
et al. [2005], reported that cytochrome c was
easily released from permeabilised mitochon-
dria than AIF, which required a more severe
treatment. Thus, while cytochrome c is nor-
mally soluble in the intermembrane space, AIF
seems to be partly attached to themitochondrial
inner membrane [Uren et al., 2005]. z-VDVAD-
fmk alone also decreased the ability to reduce
MTT, which depends on the overall cellular
reducing capacity, without affecting the mito-
chondrial membrane potential or the integrity
of the plasma membrane. These observations
suggest that the inhibitor per se interferes with
mitochondrial permeabilization without affect-
ing mitochondrial function.
In the presence of 1 mM 3-NP both caspase-
dependent and -independent cell death occur, as
indicated by caspase-2 and -3 activation and
release of AIF from mitochondria. Although
caspase-3-like activity was completely blocked
by z-VDVAD-fmk, this inhibitor only partly
prevented chromatin fragmentation/condensa-
tion induced by 3-NP, suggesting that AIF may
have contributed to the nuclear morphology
observed. Wang et al. [2003] reported the
involvement of these two pathways in cell death
occurring in ST14A striatal cells stably expres-
sing a mutant huntingtin truncation and in
10.5 weeks-old R6/2 mice, two HD models. AIF
appears also to play an important role in several
experimental models of neurodegeneration,
including the death of photoreceptors induced
by retinal detachment [Hisatomi et al., 2002],
the in vivo neuronal death induced by brain
trauma [Zhang et al., 2002] and cerebral
ischemia [Zhu et al., 2003], hydrogen peroxide,
peroxynitrite [Zhang et al., 2002], and the
excitotoxin N-methyl-D-aspartate [Yu et al.,
2002].
Fig. 4. Effect of z-VDVAD-fmk on cell reducing capacity and
membrane integrity upon exposure to 3-NP. The cells were
pretreated with 3 mM z-VDVAD-fmk and further exposed to 1
mM 3-NP, for 24 h. A: The reduction capacity of cells was
analysed by measuring the reduction of tetrazolium salt (MTT) to
formazan. These results were expressed as the percentage of
optical density observed in the control (untreated cells). B: The
integrity of the plasma membrane was determined by monitoring
the leakage of LDH, following the rate of conversion of NADH to
NADþ, at 340 nm. LDH released into the extracellular medium
was expressed as a percentage of total LDH activity in the cells.
Results were expressed as the mean SEM of four distinct
experiments, performed in duplicates or triplicates. Statistical
analysis: *P<0.05, ***P< 0.001, compared to untreated neu-
rons; ##P<0.01, compared to 3-NP-treated neurons.
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In conclusion, our data demonstrate that cell
death induced by 3-NP, used to model mito-
chondrial dysfunction in HD, involves both
caspase activation and mitochondrial release
of AIF. z-VDVAD-fmk completely blocked the
caspase-dependent pathway. However, it only
partly protected from 3-NP-mediated cell death
involving chromatin fragmentation/condensa-
tion. Thus, therapeutic strategies aimed at
blocking both caspase-dependent and -indepen-
dent pathways may protect against mitochon-
drial deregulation associated with neuronal
loss in HD.
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